Panacea-Serum Team Up To Take Six-In-One Vaccine Global

Panacea Biotec has allied with the world’s largest-vaccine maker, the Serum Institute of India, to ramp up production of a six-in-one jab aimed at preventing killer diseases like polio and diphtheria and target a global market estimated to be worth over $1.25bn annually.

Hand Shake
PANACEA AND SERUM INSTITUTE HAVE JOINED HANDS FOR THE HEXAVALENT VACCINE

Panacea Biotec Ltd., a leading Indian biotechnology firm, has combined forces with the Serum Institute of India Ltd. to expand production and global supplies of Panacea’s hexavalent vaccine.

Last March Panacea launched a fully liquid hexavalent combination vaccine, EasySix, to be administered to newborn babies to prevent six...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip